24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BiomX
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:06
Intel settles case with Jewish ex-employee who alleged antisemitic retaliation
17:18
Bybit breach: How hackers stole $1.5 billion without breaking blockchain security
15:07
Adi Dangot Zukovsky joins Ibex Investors as partner following fund’s leadership shift
14:54
‘It was through their lies that they became multimillionaires’: Charlie Javice fraud trial opens
More stories
Buzz
Most popular
Daily
Weekly
1
Adi Dangot Zukovsky joins Ibex Investors as partner following fund’s leadership shift
2
‘It was through their lies that they became multimillionaires’: Charlie Javice fraud trial opens
3
Yad2 now valued at $420 million as investors line up for potential sale
4
Tel Aviv real estate reaches new peak at over $45,000 per sqm
5
Kenny Rozenberg's healthcare group sells nursing subsidiary for hundreds of millions of dollars
More news
BiomX
3 stories about BiomX
Biomed Company BiomX Merges With New York-Listed Chardan Healthcare
17.07.19
|
Meir Orbach
BiomX develops customized therapies for conditions such as acne and inflammatory bowel disease
Phage Therapies Company BiomX Raises $32 Million
20.02.19
|
Amarelle Wenkert
BiomX develops customized therapies based on bacteriophages—viruses that invade bacterial cells and can be used to treat infections
Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration
13.12.18
|
Lilach Baumer
Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics